---
title: "风雨50年：NK细胞研究的五个阶段"
date: 2024-10-15T06:51:12Z
draft: ["false"]
tags: [
  "fetched",
  "闲谈 Immunology"
]
categories: ["Acdemic"]
---
风雨50年：NK细胞研究的五个阶段 by 闲谈 Immunology
------
<div><section data-mpa-powered-by="yiban.io"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzU1NTg4OTM3Mg==&amp;mid=2247904610&amp;idx=2&amp;sn=8b1468e35a20a2a86c49fb78ded65e05&amp;chksm=fbc58ad1ccb203c7790d8d81ae9e507f1d5b5311a77541b34c05645884d8039004add0264d36&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="1" hasload="1"><span><img data-galleryid="" data-imgfileid="100038924" data-ratio="0.42592592592592593" data-s="300,640" data-type="png" data-w="1080" data-src="https://mmbiz.qpic.cn/mmbiz_png/qygMQht6xpbHpSb1oCYxpOEDOYzCqpraXokC4ia1McrPticrc8VibGLj97WKbRzGVLfQT4Aib8MjAX3Jq4w5ljXUow/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;tp=webp&amp;wx_lazy=1&amp;wx_co=1" src="https://mmbiz.qpic.cn/mmbiz_png/qygMQht6xpbHpSb1oCYxpOEDOYzCqpraXokC4ia1McrPticrc8VibGLj97WKbRzGVLfQT4Aib8MjAX3Jq4w5ljXUow/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;tp=webp&amp;wx_lazy=1&amp;wx_co=1"></span></a></section><p><span>1. 早期研究（1973 - 1982）</span></p><ul><ul><li><section><span>1973 年，研究发现正常淋巴细胞对肿瘤细胞有低水平细胞毒性反应。</span></section></li><li><section><span>1975 年，Kiessling 等人将对肿瘤细胞的 “自然杀伤” 能力命名为 NK 细胞，并发现 NK1.1。</span></section><section><span>Kiessling, R., E. Klein, H. Pross, and H. Wigzell. 1975a. “Natural” killer cells inthe mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur. J. Immunol. 5:117–121.</span></section></li><li><section><span>研究表明 NK 细胞不同于 MHC 限制的 T 细胞，可自发杀伤肿瘤细胞，且这种杀伤活性不仅在体外存在，在体内也可发生。</span></section></li></ul></ul><section><span> 2. 细胞特征与功能探索（1983 - 1992）</span></section><ul><ul><li><section><span>形态学：1979将 NK 细胞描述为 “大颗粒淋巴细胞”。</span></section><section><span>Timonen, T., E. Saksela, A. Ranki, and P. Hayry. 1979. Fractionation, mor- ¨phological and functional characterization of effector cells responsiblefor human natural killer activity against cell-line targets. Cell. Immunol.48:133–148</span></section></li><li><section><span>1983 年，人类 NK 细胞首次通过激活 Fc 受体 CD16 和碳水化合物抗原 CD57 的表达确定了功能不同的亚群，之后发现外周血中主要的 NK 细胞亚群可通过 CD56bright,CD16−和 CD56dim,CD16 + 进行区分。</span></section><section><span>Lanier, L.L., A.M. Le, J.H. Phillips, N.L. Warner, and G.F. Babcock. 1983.Subpopulations of human natural killer cells defined by expression ofthe Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131:1789–1796.</span><span></span></section></li><li><section><span>研究发现 NK 细胞优先杀伤缺乏 MHC I 类分子的肿瘤细胞，为理解先天免疫系统对病毒和肿瘤的防御机制提供了新视角。同时，明确了 NK 细胞是一种独特的淋巴细胞谱系（<span>与 T 细胞不同</span>）。</span></section><section><span>Lanier, L.L., S. Cwirla, N. Federspiel, and J.H. Phillips. 1986a. Human naturalkiller cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes. J. Exp. Med. 163:209–214. https://doi.org/10.1084/jem.163.1.209</span></section><section><span>Lanier, L.L., S. Cwirla, and J.H. Phillips. 1986b. Genomic organization of T cellgamma genes in human peripheral blood natural killer cells. J. Immunol.137:3375–3377</span></section><section><span>Lanier, L.L., A.M. Le, C.I. Civin, M.R. Loken, and J.H. Phillips. 1986c. Therelationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression onhuman peripheral blood NK cells and cytotoxic T lymphocytes.J. Immunol. 136:4480–4486.</span></section><section><span>Lanier, L.L., J.H. Phillips, J. Hackett Jr., M. Tutt, and V. Kumar. 1986d. Naturalkiller cells: Definition of a cell type rather than a function. J. Immunol.137:2735–2739</span></section><section><span><strong><span><span> Lewis Lanier</span>是这方面最重要的科学家之一。</span></strong></span></section></li><li><section><span>1989 年，发现首例完全缺乏 NK 细胞但有 B 和 T 淋巴细胞且能产生抗体的人类患者，感染疱疹病毒，这明确了 NK 细胞在抗感染免疫中的重要作用。</span></section></li><li><section><span>这一时期还发现了许多 NK 细胞的激活和抑制受体相关基因，以及对 NK 细胞产生 IFN - γ。</span></section><section><span>Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Posp´ısil, H.A. Young,S.F. Wolf, D. Young, S.C. Clark, and G. Trinchieri. 1991. Induction ofinterferon gamma production by natural killer cell stimulatory factor:Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869–8</span></section></li></ul></ul><section><span>3. 受体研究的深入（1993 - 2002）</span></section><ul><ul><li><section><span>基于 “missing - self” 假说，发现了抑制性的小鼠 Ly49 受体和人类 KIR 受体，以及它们识别的 MHC I 类分子配体，同时也发现了激活受体与抑制受体的平衡对 NK 细胞反应的调节作用。</span></section><section><span>Karlhofer, F.M., R.K. Ribaudo, and W.M. Yokoyama. 1992. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature.358:66–70</span></section><section><span>Colonna, M., and J. Samaridis. 1995. Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human NK cells. Science.268:405–408</span></section></li><li><section><span>发现了 “自然细胞毒性受体”-NKp30、NKp44 和 NKp46 等参与 NK 细胞对肿瘤的识别，以及相关信号转导机制。还确定了 NKG2D 受体的配体，其在细胞应激时表达，是 NK 细胞 “altered - self” 识别的基础。</span></section></li><li><section><span>2002 年发现小鼠 NK 细胞具有针对小鼠 CMV 抗原的特异性受体，挑战了天然免疫细胞无抗原特异性识别的传统观点。</span></section><section><span>Arase, H., E.S. Mocarski, A.E. Campbell, A.B. Hill, and L.L. Lanier. 2002.Direct recognition of cytomegalovirus by activating and inhibitory NKcell receptors. Science. 296:1323–1326.</span></section></li></ul></ul><section><span>4. 记忆与授权现象的发现（2003 - 2012）</span></section><ul><ul><li><section><span>2006 年观察到小鼠 NK 细胞可介导半抗原特异性接触超敏反应，之后验证了 NK 细胞的抗原特异性反应能力，包括 Ly49H+ NK 细胞在 MCMV 感染中的克隆扩增和保护反应。</span></section></li><li><section><span>发现缺乏自我 MHC I 类分子同源配体的 NK 细胞亚群比具有抑制性 Ly49 受体的 NK 细胞反应性低，这就是NK 细胞的 “授权（<span>licensing</span>）” 。</span></section><section><span>Kim, S., J. Poursine-Laurent, S.M. Truscott, L. Lybarger, Y.J. Song, L. Yang,A.R. French, J.B. Sunwoo, S. Lemieux, T.H. Hansen, and W.M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 436:709–71</span></section></li></ul></ul><section><span>5. 多样性与临床应用探索（2013 - 至今）</span></section><ul><ul><li><section><span>2013 年利用新技术发现健康成人外周血中 NK 细胞群体具有高度的表型多样性，单细胞转录分析进一步强调了这种多样性。</span></section></li><li><section><span>研究揭示了 CMV 感染对小鼠和人类 NK 细胞的表观遗传变化影响，尤其是对人类记忆或适应性 NK 细胞的改变。</span></section><section><span>NK 细胞治疗方面，2020 年首次将 CD19 嵌合抗原受体 NK 细胞用于淋巴瘤患者治疗取得了令人鼓舞的结果，同时 NK 细胞 engagers 的研究也在推进。</span></section><section><span>Liu, E., D. Marin, P. Banerjee, H.A. Macapinlac, P. Thompson, R. Basar, L.Nassif Kerbauy, B. Overman, P. Thall, M. Kaplan, et al. 2020. Use ofCAR-transduced natural killer cells in CD19-positive lymphoid tumors.N. Engl. J. Med. 382:545–553</span></section><section><span></span><span></span></section><section><mp-common-profile data-pluginname="mpprofile" data-id="Mzg2OTczNjI0OQ==" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicSUg9Zeq93L0JONScSZFlntu2ygj7iaq0trvU3x8sot8hpJ5U6PmtPsys5kiaqkTv364qWAdIQgqoSQ/0?wx_fmt=png" data-nickname="闲谈 Immunology" data-alias="xiantanimmunology" data-signature="专注ImmunoBiology，桥接基础研究与产业应用！" data-from="0"></mp-common-profile></section></li></ul></ul><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/n6LpgAjAa_yk7gKoWz76jQ",target="_blank" rel="noopener noreferrer">原文链接</a>
